OCTREOTIDE IN THE MANAGEMENT OF INOPERABLE GASTROINTESTINAL OBSTRUCTION IN TERMINAL CANCER-PATIENTS

被引：40
|
作者：
MERCADANTE, S
MADDALONI, S
机构：
[1] Department of Anesthesia, Buccheri La Ferla Fatebenefratelli Hospital, Pain Relief and Palliative Care Unit, Palermo
来源：
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | 1992年 / 7卷 / 08期
关键词：
D O I：
10.1016/0885-3924(92)90137-7
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：496 / 498
页数：3
相关论文
共 50 条
  • [1] THE MANAGEMENT OF INOPERABLE GASTROINTESTINAL OBSTRUCTION IN TERMINAL CANCER-PATIENTS
    VENTAFRIDDA, V
    RIPAMONTI, C
    CARACENI, A
    SPOLDI, E
    MESSINA, L
    DECONNO, F
    TUMORI, 1990, 76 (04) : 389 - 393
  • [2] MANAGEMENT OF BOWEL OBSTRUCTION IN ADVANCED AND TERMINAL CANCER-PATIENTS
    RIPAMONTI, C
    DECONNO, F
    VENTAFRIDDA, V
    ROSSI, B
    BAINES, MJ
    ANNALS OF ONCOLOGY, 1993, 4 (01) : 15 - 21
  • [3] Octreotide in the management of bowel obstruction in terminal ovarian cancer
    Mangili, G
    Franchi, M
    Mariani, A
    Zanaboni, F
    Rabaiotti, E
    Frigerio, L
    Bolis, PF
    Ferrari, A
    GYNECOLOGIC ONCOLOGY, 1996, 61 (03) : 345 - 348
  • [4] The use of steroids in the management of inoperable intestinal obstruction in terminal cancer patients:: do they remove the obstruction?
    Laval, G
    Girardier, J
    Lassaunière, JM
    Leduc, B
    Haond, C
    Schaerer, R
    PALLIATIVE MEDICINE, 2000, 14 (01) : 3 - 10
  • [5] MANAGEMENT OF BOWEL OBSTRUCTION IN ADVANCED CANCER-PATIENTS
    RIPAMONTI, C
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1994, 9 (03) : 193 - 200
  • [6] METHYLPHENIDATE FOR THE MANAGEMENT OF SOMATIZATION IN TERMINAL CANCER-PATIENTS
    VIGANO, A
    WATANABE, S
    BRUERA, E
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1995, 10 (02) : 167 - 170
  • [7] BOWEL OBSTRUCTION IN CANCER-PATIENTS
    TANG, E
    DAVIS, J
    SILBERMAN, H
    ARCHIVES OF SURGERY, 1995, 130 (08) : 832 - 837
  • [8] Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction
    S. Mercadante
    C. Ripamonti
    A. Casuccio
    E. Zecca
    L. Groff
    Supportive Care in Cancer, 2000, 8 : 188 - 191
  • [9] Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction
    Mercadante, S
    Ripamonti, C
    Casuccio, A
    Zecca, E
    Groff, L
    SUPPORTIVE CARE IN CANCER, 2000, 8 (03) : 188 - 191
  • [10] COMMUNICATING WITH TERMINAL CANCER-PATIENTS
    ANDERSON, JL
    PATIENT COUNSELLING AND HEALTH EDUCATION, 1980, 2 (01): : 28 - 31
12345